Business Wire

Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 565-576 of 19109

Masar Promenade View (Photo: AETOSWire)

Umm Al Qura for Development & Construction Company Concludes Participation in Real Estate Future Forum 2026

Fôret Restaurant, Dublin

Ireland Takes Centre Stage as MICHELIN Awards Come to Dublin for the First Time

MultiBank Group has announced the launch of two limited-time promotional programs designed to reward both its Introducing Broker network and retail trading clients.

MultiBank Group Launches 50% Rebate Boost for IBs & 25% Deposit Bonus for Clients

Ticket Safety Expert, Nick Hawe, warns that government ticket resale price caps could push fans onto risky social media scams and urges using safe, regulated platforms with consumer protections; visit Get Safe Online for tools to stay protected.

Cybercrime Expert Warns: 55% Of Brits Fail to Spot Fraudulent Tickets on Social Media and Price Caps Could Make Scams Worse

Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution

Love, Actually… Comes With a Back-Up Plan: 30m Brits Saving for a Break-Up

Square AI is a conversational assistant that turns everyday business data into clear, actionable insight. (Graphic: Square)

Introducing Square AI: Helping UK Small Businesses Turn Instinct Into Confident Decisions

New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval

Business Wire embedded0

IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence

OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners

Exchange Any Asset, Anytime, Anywhere: LMAX Group Introduces Omnia Exchange, Built for the Digital Capital Markets of the Future

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1